Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona

被引：0

作者：

Xavier Solanich

Raúl Rigo-Bonnin

Victor-David Gumucio

Paul Bastard

Jérémie Rosain

Quentin Philippot

Xosé-Luis Perez-Fernandez

Maria-Paz Fuset-Cabanes

Miguel-Ángel Gordillo-Benitez

Guillermo Suarez-Cuartin

Enric Boza-Hernandez

Antoni Riera-Mestre

Alba Parra-Martínez

Roger Colobran

Arnau Antolí

Sergio Navarro

Gemma Rocamora-Blanch

Mario Framil

Laura Calatayud

Xavier Corbella

Jean-Laurent Casanova

Francisco Morandeira

Joan Sabater-Riera

机构：

[1] Hospital Universitari de Bellvitge,Department of Internal Medicine

[2] L’Hospitalet de Llobregat,Department of Clinical Laboratory

[3] Bellvitge Biomedical Research Institute (IDIBELL),Department of Intensive Care

[4] L’Hospitalet de Llobregat,Laboratory of Human Genetics of Infectious Diseases, Necker Branch

[5] Hospital Universitari de Bellvitge,Imagine Institute

[6] L’Hospitalet de Llobregat,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch

[7] Hospital Universitari de Bellvitge,Department of Respiratory Medicine

[8] L’Hospitalet de Llobregat,Department of Anesthesiology

[9] INSERM U1163,Faculty of Medicine and Health Sciences

[10] Necker Hospital for Sick Children,Infection in Immunocompromised Pediatric Patients Research Group

[11] University of Paris,Pediatric Infectious Diseases and Immunodeficiencies Unit

[12] The Rockefeller University,Immunology Division, Genetics Department

[13] Hospital Universitari de Bellvitge,Diagnostic Immunology Research Group

[14] L’Hospitalet de Llobregat,Immunology Unit. Department of Cellular Biology, Physiology and Immunology

[15] Hospital Universitari de Bellvitge,Department of Immunology

[16] L’Hospitalet de Llobregat,Department of Microbiology

[17] Universitat de Barcelona,School of Medicine

[18] Vall d’Hebron Institut de Recerca (VHIR),undefined

[19] Vall d’Hebron Barcelona Hospital Campus,undefined

[20] Hospital Universitari Vall d’Hebron,undefined

[21] Vall d’Hebron Barcelona Hospital Campus,undefined

[22] Hospital Universitari Vall d’Hebron,undefined

[23] Vall d’Hebron Barcelona Hospital Campus,undefined

[24] Vall d’Hebron Institut de Recerca (VHIR),undefined

[25] Vall d’ Hebron Barcelona Hospital Campus,undefined

[26] Universitat Autònoma de Barcelona (UAB),undefined

[27] Hospital Universitari de Bellvitge,undefined

[28] L’Hospitalet de Llobregat,undefined

[29] Hospital Universitari de Bellvitge,undefined

[30] L’Hospitalet de Llobregat,undefined

[31] Universitat Internacional de Catalunya,undefined

[32] Howard Hughes Medical Institute,undefined

来源：

Journal of Clinical Immunology | 2021年 / 41卷

关键词：

COVID-19; SARS-CoV-2; acute kidney injury; type I interferons; auto-antibodies;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1733 / 1744

页数：11

共 50 条

[1] Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
Solanich, Xavier
Rigo-Bonnin, Raul
Gumucio, Victor-David
Bastard, Paul
Rosain, Jeremie
Philippot, Quentin
Perez-Fernandez, Xose-Luis
Fuset-Cabanes, Maria-Paz
Gordillo-Benitez, Miguel-Angel
Suarez-Cuartin, Guillermo
Boza-Hernandez, Enric
Riera-Mestre, Antoni
Parra-Martinez, Alba
Colobran, Roger
Antoli, Arnau
Navarro, Sergio
Rocamora-Blanch, Gemma
Framil, Mario
Calatayud, Laura
Corbella, Xavier
Casanova, Jean-Laurent
Morandeira, Francisco
Sabater-Riera, Joan
JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (08) : 1733 - 1744
[2] Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care
Rowan, Courtney M.
LaBere, Brenna
Young, Cameron C.
Zambrano, Laura D.
Newhams, Margaret M.
Kucukak, Suden
McNamara, Elizabeth R.
Mack, Elizabeth H.
Fitzgerald, Julie C.
Irby, Katherine
Maddux, Aline B.
Schuster, Jennifer E.
Kong, Michele
Dapul, Heda
Schwartz, Stephanie P.
Bembea, Melania M.
Loftis, Laura L.
Kolmar, Amanda R.
Babbitt, Christopher J.
Nofziger, Ryan A.
Hall, Mark W.
Gertz, Shira J.
Cvijanovich, Natalie Z.
Zinter, Matt S.
Halasa, Natasha B.
Bradford, Tamara T.
McLaughlin, Gwenn E.
Singh, Aalok R.
Hobbs, Charlotte V.
Wellnitz, Kari
Staat, Mary A.
Coates, Bria M.
Crandall, Hillary R.
Maamari, Mia
Havlin, Kevin M.
Schwarz, Adam J.
Carroll, Christopher L.
Levy, Emily R.
Moffitt, Kristin L.
Campbell, Angela P.
Randolph, Adrienne G.
Chou, Janet
CLINICAL INFECTIOUS DISEASES, 2024, 79 (02) : 395 - 404
[3] Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
Vazquez, Sara E.
Bastard, Paul
Kelly, Kathleen
Gervais, Adrian
Norris, Philip J.
Dumont, Larry J.
Casanova, Jean-Laurent
Anderson, Mark S.
DeRisi, Joseph L.
JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1169 - 1171
[4] Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
Sara E. Vazquez
Paul Bastard
Kathleen Kelly
Adrian Gervais
Philip J. Norris
Larry J. Dumont
Jean-Laurent Casanova
Mark S. Anderson
Joseph L. DeRisi
Journal of Clinical Immunology, 2021, 41 : 1169 - 1171
[5] Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Chauvineau-Grenier, Angelique
Bastard, Paul
Servajean, Antoine
Gervais, Adrian
Rosain, Jeremie
Jouanguy, Emmanuelle
Cobat, Aurelie
Casanova, Jean-Laurent
Rossi, Benjamin
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (03) : 459 - 470
[6] Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Angélique Chauvineau-Grenier
Paul Bastard
Antoine Servajean
Adrian Gervais
Jérémie Rosain
Emmanuelle Jouanguy
Aurélie Cobat
Jean-Laurent Casanova
Benjamin Rossi
Journal of Clinical Immunology, 2022, 42 : 459 - 470
[7] Autoantibodies neutralizing type III interferons are uncommon in patients with severe COVID-19 pneumonia
Vanker, Martti
Sarekannu, Karita
Haljasmagi, Liis
Kallaste, Anne
Kisand, Kalle
Lember, Margus
Peterson, Part
Kisand, Kai
EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1695 - 1695
[8] Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
Flythe, Jennifer E.
Assimon, Magdalene M.
Tugman, Matthew J.
Chang, Emily H.
Gupta, Shruti
Shah, Jatan
Sosa, Marie Anne
Renaghan, Amanda DeMauro
Melamed, Michal L.
Wilson, F. Perry
Neyra, Javier A.
Rashidi, Arash
Boyle, Suzanne M.
Anand, Shuchi
Christov, Marta
Thomas, Leslie F.
Edmonston, Daniel
Leaf, David E.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (02) : 190 - +
[9] Similar Kinetics of Pulmonary SARS-CoV-2 Load in Intensive Care Unit Patients with COVID-19 Pneumonia with or Without Autoantibodies Neutralizing Type I Interferons
Valentine Le Stang
Paul Bastard
Elise Langouet
Marc Pineton de Chambrun
Juliette Chommeloux
Adrian Gervais
Lucy Bizien
Anne Puel
Aurélie Cobat
Julien Mayaux
Alexandre Demoule
Jean-Laurent Casanova
David Boutolleau
Alain Combes
Sonia Burrel
Charles-Edouard Luyt
Journal of Clinical Immunology, 2025, 45 (1)
[10] The effect of dexamethasone on patients admitted with covid-19 who had pre-existing diabetes
Blunt, T.
Neish, R.
Kurian, M.
James, S.
Kalathil, D.
DIABETIC MEDICINE, 2022, 39

← 1 2 3 4 5 →